Johns Hopkins Kimmel Cancer Center Podcasts: Recent Episodes
Johns Hopkins Kimmel Cancer Center
The Johns Hopkins Kimmel Cancer Center leads the field in scientific inquiry and sets the pace in the race to cure cancer. Our doctors and researchers are at the vanguard of discovery, implementation and treatment. Our podcast provides a glimpse at the work they do to combat cancer and the leading care that our state-of-the-art facilities provide.
Dr Bill Nelson and Dr Michael Desjardins discuss the role geography plays in determining how we approach the treatment of cancer is different communities. To learn more about the Cancer InFocus program, visit cif.jhmi.edu.
Dr Bill Nelson and Dr Mike Carducci examine the latest hormone target therapies for prostate cancer, their side effect profiles and the evolution of individualized treatments.
Dr Akila Viswanathan speaks with Dr Thomas DeLaney from the Dartmouth Cancer Center and Dr Alexander Ruhle from the University of Leipzig Medical Center about an issue of Seminars in Radiation Oncology entitled Functional Radiotherapy for Non-Malignant Diseases: The Potential of Ionizing Radiation Beyond Cancer Treatment.
Dr Bill Nelson and Dr Elizabeth Jaffee discuss two significant breakthroughs in pancreatic cancer. The first is daraxonrasib, a drug that has significantly prolonged survival in patients with metastatic pancreatic cancer and a new vaccine targeting mutations that cause the disease and that could potentially go as far as preventing it altogether.
Dr Bill Nelson talks to thoracic surgeon, Dr Stephen Yang, about the developments in lung cancer surgery that have resulted in more minimally invasive procedures and improved patient outcomes.
Dr Bill Nelson talks with YouTuber and science communicator Hank Green about his diagnosis and treatment for Hodgkin lymphoma, the quickening of advances in cancer therapies and the most likely areas for future care breakthroughs.
May is Melanoma Awareness Month. In this episode, Dr Bill Nelson and Dr Ashani Weeraratna explain the causes of melanoma and what you can do to reduce your risk for skin cancers.
In this episode, we tackle a critical and often unsettling subject of the history of racial ethics in healthcare. This discussion is not just about looking back at the past, but about understanding how historical injustices continue to influence present-day healthcare practices and perceptions. The history of racial ethics in healthcare is complex and fraught with ethical breaches that have left deep scars in communities, particularly among African Americans. Perhaps one of the most infamous examples is the Tuskegee Syphilis Study. Conducted between 1932 and 1972, this study involved hundreds of African American men who were misled and denied proper treatment for syphilis. This egregious violation of ethical standards was justified at the time by prevailing racist ideologies that dehumanized Black individuals and viewed them as suitable subjects for experimentation.
Today we delve into a pressing issue that challenges conventional perceptions about cancer – its increasing prevalence among younger populations. Traditionally, cancer has predominantly affected individuals over the age of 50. However, recent years have seen a troubling rise in cases among those under 40, a demographic historically viewed as less susceptible. In this episode, we explore the evolving landscape of cancer in young people, discussing emerging trends, risk factors, and the unique challenges faced by this age group. With expert insights from Dr Otis Brawley, we'll uncover how lifestyle, genetic predispositions, and advancements in early detection play a role in these shifting trends. We'll also discuss how healthcare systems can adapt to better serve young cancer patients, ensuring equitable access to prevention, treatment, and care.
Dr Otis Brawley sheds light on the often-confusing world of cancer statistics by explaining the crucial differences between survival rates and death rates. He delves into how increased survival rates can paradoxically correlate with higher mortality rates and the factors that contribute to this complex relationship. Dr Brawley addresses common misconceptions about cancer statistics and offers practical advice for healthcare professionals on effectively communicating these nuances to patients. The episode also highlights the potential pitfalls of using survival rates as the sole metric for treatment success, the role of early detection in shaping public perception, and the importance of responsible media reporting.
Discover effective strategies for reducing racial, economic, and social inequalities in cancer prevention and treatment as Dr Otis Brawley shares insights on integrating research into culturally sensitive programs. Explore the vital role of community organizations in cancer control and learn from impactful initiatives that have transformed underserved communities. Looking towards the future, Dr Brawley highlights his priorities for advancing cancer control with technology and innovation, offering valuable advice to those embarking on a career in this critical field.
Dr Bill Nelson talks to Dr Christian Pavlovich, a urologic oncologist, about the ever-expanding treatment options available for patients with prostate cancer in Washington DC.
Dr Bill Nelson talks with Dr Richard Dotson about his book, Unbroken, detailing the story of his diagnosis, treatment, and recovery from pancreatic cancer. Dr Dotson's oncologist at Johns Hopkins, Dr Daniel Laheru, also joins the podcast to discuss his diagnosis and care plan.
Learn more about Dr Dotson's book ➡️ https://amzn.to/4qJfVCp
Dr Bill Nelson speaks with Dr Gabriel Ivey, a gastrointestinal surgeon based in the National Capital Region, about his practice, the progress being made in patient outcomes, and the range of care options available at Johns Hopkins in the greater Washington DC area.
This is Healthcare Quality Week. In this podcast, Dr Bill Nelson talks with Yanka Campbell and Dr Allen Chen about improving the quality of care by implementing standards that have positively impacted patient safety and reduced adverse events.
Dr Akila Viswanathan talks with Dr Amol Narang about the latest edition of Seminars in Radiation Oncology focused on the multidisciplinary treatment of pancreatic cancer.
Dr Akila Viswanathan speaks with Johns Hopkins Radiation Oncology and Molecular Radiation Sciences faculty in attendance at the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco to review the conference and provide updates on how the information presented will impact patient care.
Dr Sahaja Acharya discusses soft tissue sarcomas.
Dr Daniel Song reviews a range of studies on prostate cancer.
Dr Ana Kiess describes the current state of radiopharmacueticals.
Dr Lawrence Kleinberg updates the progress being made in the treatment of central nervous system malignancies.
Dr Bill Nelson talks to Dr Catherine Handy Marshall about the broader range or treatments available for advanced prostate cancer at the Johns Hopkins Kimmel Cancer Center that are leading to better outcomes, fewer side-effects and longer survival.
Dr Bill Nelson and Dr Sam Denmeade discuss the growing array of treatments for patients with prostate cancer available at the Johns Hopkins Kimmel Cancer Center.
Dr Bill Nelson talks to Dr John Gross, a surgical pathologist, about the diagnosis of sarcomas, tumors most commonly found in bones and soft tissue. Dr Gross recently published a paper in Modern Pathology on his team's discovery of a new type of soft tissue tumor. Read more about that here.
Dr Bill Nelson and Dr Michael Pishvaian discuss the targeting of KRAS mutations in pancreatic cancer to develop new treatment options for a disease that has been historically difficult to care for.
Dr Bill Nelson and Dr Cynthia Sears discuss the role of the microbiome on our overall health, how it impacts cancer risk and the crucial role of federal research funding in understanding these organisms.
Dr Bill Nelson and Dr Nilo Azad discuss the decades-long research effort to develop treatments targeting KRAS mutations and the importance of federal funding in bringing those treatments to patients.
Dr Bill Nelson and Dr Michael Carducci discuss using Prostate-Specific Membrane Antigen (PSMA) targeted therapies to detect and treat prostate cancer.
Dr Akila Viswanathan speaks with Dr Sophia Kamran from Harvard Medical School and Dr Constantinos Zamboglou from the German Oncology Center about the latest edition of Seminars in Radiation Oncology focusing on new treatments for advanced prostate cancer.
Dr Bill Nelson talks to Dr Elizabeth Platz about her research studying the causes of cancer over time in large groups and using data to assess future risk.
Dr Bill Nelson and Dr Bert Vogelstein discuss the development of tools for the early detection of cancers, which will lead to better treatments with fewer long-term consequences for patients.
Dr Bill Nelson speaks with Dr Kala Visvanathan about her research assessing breast cancer risk, why many people are developing cancers earlier in life, and the tools she is developing to find cancer sooner, when it can be treated more effectively.
Dr Bill Nelson and Dr Chi Dang discuss the impact of circadian rhythms on our metabolism and how researchers are working to utilize this knowledge to improve cancer treatment.
Dr Bill Nelson talks to Dr Andrew Ewald, a cell biologist, about his research into how cancer cells migrate throughout the body and the importance of federal funding to continue building on decades of successful research efforts.
Dr Bill Nelson speaks with Dr Elizabeth Jaffee about her research in cancer vaccines, immunotherapy, and the importance of federal funding in continuing to achieve breakthroughs in cancer treatment.
Dr Bill Nelson talks with Dr Denis Wirtz about his research using CODA, an artificial intelligence platform, to identify and analyze pre-cancerous lesions previously undetected in the pancreas and along the fallopian tubes.
Dr Bill Nelson talks with Dr Ashani Weeraratna about her work in melanoma research, the progress that has been made in treating patients with melanoma, and the importance of federal research funding in finding advancements in treatment for this disease.
Dr Bill Nelson talks to Dr Drew Pardoll about the field of cancer immunology. They explain how cancer cells use 'checkpoints' to turn off immune response and how research efforts at Johns Hopkins to block these checkpoints and re-engage the immune system continue to benefit patients.
Dr Bill Nelson talks with Dr Christine Pratilas, the new Director of Pediatric Oncology at the Johns Hopkins Kimmel Cancer Center, about the care of children with sarcoma and the importance of research funding in discovering new treatments for childhood cancers.
Dr Bill Nelson talks with Dr Christian Meyer about being named the Johns Hopkins Hospital Physician of the Year and treating patients with sarcoma. Read more ➡️ https://bit.ly/3XFAt2R
Dr Akila Viswanathan speaks with Dr Robert Coppes from The University Medical Center Groningen, Dr David Jaffray from MD Anderson Cancer Center and Dr Helen McNair from The Royal Marsden NHS Foundation Trust Institute of Cancer Research to look ahead to the future of radiation oncology as they discuss how to improve decision making, incorporating artificial intelligence, adapt to new training methods, improve safety and sustainability and much more for Seminars in Radiation Oncology.
Dr Bill Nelson and Dr Vasan Yegnasubramanian review the latest developments in artificial intelligence that are improving cancer treatment. They highlight how radiology and pathology are at the forefront of this technology and explore areas where using AI and data analysis can open more avenues to improving care.
Dr Bill Nelson and Dr Eugene Shenderov discuss the Johns Hopkins Prostate Cancer Multidisciplinary Clinic. They provide an overview, including who participates in reviewing a patient's diagnosis, the schedule of their initial visit and how the team develops a treatment plan. Learn more about the Prostate Cancer Multidisciplinary Clinic here.
In this Cancer Matters podcast, Dr Bill Nelson speaks with Dr Nina Wagner-Johnston about the treatment of lymphoma and the newly opened Cellular Therapy Program at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington DC.
Lymphoma is a blood cancer of the immune system. There are many types of lymphomas with a broad range of aggressiveness and clinical behaviors but they are also among the most treatable. Learn more about the different types of lymphomas here.
The Cellular Therapy Program at Sibley Memorial Hospital makes bone marrow transplants more readily available in the Washington DC region allowing patients to remain closer to home while receiving treatment.
In this edition of the On Target podcast, Dr Akila Viswanathan speaks with Dr Kristin Redmond about treating brain and spinal tumors and her research on stereotactic body radiation therapy (SBRT).
Dr Redmond discusses some ongoing clinical trials using SBRT, a highly precise form of radiation therapy used to treat tumors in while minimizing damage to surrounding areas, that are exploring optimal doses and treatment techniques to improve patient outcomes.
They also highlight the benefits of collaboration in multidisciplinary care at Johns Hopkins, where experts from radiation oncology, medical oncology, surgery, radiology and other fields work together to provide the best possible care for patients with complex cases, including rare tumors.
Dr Redmond also touches on the innovative use of circulating tumor DNA to detect tumor recurrence early and her research on the neuropsychological effects of radiation on the brain.
Dr Akila Viswanathan begins a special series focusing on women in radiation oncology at Johns Hopkins in this edition of the On Target podcast. Today she speaks with Dr Ana Kiess about treating patients with prostate cancer and head and neck cancers, her research on the integration of radiopharmaceutical therapies, and the unique challenges women face in academic medicine while balancing leadership roles, research, and clinical responsibilities.
Radiopharmaceuticals are a specialized group of drugs containing radioisotopes that emit radiation. They are used primarily in nuclear medicine and oncology for diagnostic and therapeutic purposes. These treatments deliver targeted radiation doses directly to tumors, damaging the cancer cells’ DNA and preventing their growth and spread. Dr Kiess highlights the ongoing clinical trials and advancements in radiopharmaceutical therapies, which are opening new possibilities for cancer treatment, especially in cases of prostate cancer.
The discussion also emphasizes the collaborative environment at Johns Hopkins, where specialists from multiple disciplines work together to advance the field. Dr Kiess explains how this collaborative approach enhances research and patient care, allowing for the development of innovative treatment protocols that can more effectively target cancers.
October is Breast Cancer Awareness Month. In this episode of the Cancer Matters podcast, Dr Bill Nelson, Director of the Johns Hopkins Kimmel Cancer Center, speaks with Dr John Fetting and Dr Antonio Wolff about the breast cancer program at Johns Hopkins and the Fetting Fund for Breast Cancer Prevention.
The Fetting Fund was inspired by the breast cancer journey of one of Dr Fetting’s patients, Leslie Ries, and supports research to better understand breast cancer risk factors and develop effective prevention strategies. The goal is to empower women to make informed decisions about their health and reduce their chances of ever facing a breast cancer diagnosis.
This conversation explores some of the causes of breast cancer, like genetic mutations, the challenges physicians face in identifying those at an elevated risk, personalized prevention approaches that balance the benefits of medication with potential side effects, and the role of lifestyle factors, such as diet and exercise, in lowering the risk of breast cancer.
Visit the Fetting Fund for Breast Cancer Prevention to learn more about the research projects currently underway and what steps you can take to lower your risk.
In this Cancer Matters podcast, Dr Bill Nelson, Director of the Johns Hopkins Kimmel Cancer Center, talks with Beth Blakey and Samantha Schrager from the Cancer Hope Network about their mission providing mentorship to cancer patients, the families of patients and caregivers, and a new partnership with Johns Hopkins.
Cancer Hope Network is a peer mentorship program that provides one-on-one support for adults impacted by cancer. They connect cancer patients and caregivers with mentors who have been through similar experiences. These mentors offer guidance and understanding to those currently navigating cancer treatment, ensuring that no one goes through the journey alone.
Cancer Hope Network has grown from a local initiative to a national network of around 500 trained mentors. These mentors are volunteers who have completed treatment or have served as caregivers. They represent a wide range of cancer types and life experiences, allowing for personalized matches between mentors and those seeking support.
Earlier this Summer, the Cancer Hope Network and the Johns Hopkins Kimmel Cancer Center launched a new partnership, called the M.A.P.S. program (Mentorship and Peer Support for Patients and Caregivers). This initiative is designed to recruit mentors from within the Johns Hopkins community to provide support to newly diagnosed patients and their families.
To get matched with a mentor, become a mentor or learn more about the M.A.P.S program ➡️ cancerhopenetwork.org/skcccjh/
September is Sickle Cell Awareness Month. In this Cancer Matters podcast, Dr Bill Nelson, the Director of the Johns Hopkins Kimmel Cancer Center, speaks to Dr Rick Jones and Dr Robert Brodsky about treating sickle cell anemia, an inherited disorder where mutations in the globin gene cause the red blood cells to take on a sickle shape, leading to severe pain and organ damage. They discuss and compare the types of bone marrow transplants currently used to treat the disease and highlight the significant improvements in reducing complications, such as graft-versus-host disease and graft rejection.
In this On Target podcast, Dr Akila Viswanathan, Director of Radiation Oncology and Molecular Radiation Sciences at the Johns Hopkins Kimmel Cancer Center, speaks with Dr. Deborah Citrin from the National Cancer Institute’s Center for Cancer Research and Dr. Zachary Morris from the University of Wisconsin School of Medicine and Public Health for an issue of Seminars in Radiation Oncology focusing on personalized dose.
The discussion explores advancements in radiation therapy, including how modern technology and biology are being used to tailor radiotherapy doses to individual patients. Dr Citrin highlights the potential of integrating genomics, imaging, and biomarkers to achieve personalized treatment, while Dr Morris examines disease-specific biomarkers and their application in clinical practice.
This episode covers key topics such as using gene expression signatures to predict radiation response, leveraging imaging for adaptive therapy, and how molecular markers are helping to refine treatment decisions. They also explore the promise of circulating tumor DNA as a tool for guiding radiation dosage and the complexities of combining radiation with immunotherapy.
Dr Akila Viswanathan talks with Dr Robert Griffin from the University of Arkansas for Medical Sciences and Dr Chandan Guha from Montefiore Einstein about a recent edition of Seminars in Radiation Oncology on innovations in physics, biology and clinical translation of spatially fractionated and FLASH radiotherapy.
Dr Bill Nelson talks with Dr Matthias Holdhoff about the treatment of brain cancer and a significant FDA approval of a new drug treatment for a type of brain cancer, called low-grade glioma. The drug, called vorasidenib, is a targeted cancer therapy that works by inhibiting the activity of a mutated gene called IDH, slowing the growth of the cancer. Read more here
Dr Bill Nelson speaks with Robin Hopkins, the author of What Happens Now?, and Dr Tom Smith about how we can help children comprehend a cancer diagnosis in a loved one and encourage an open dialogue about their feelings and emotions.
Download What Happens Now? for free
Dr Akila Viswanathan speaks with Dr Charles Thomas from the Dartmouth Cancer Center and Dr Ethan Ludmir from the MD Anderson Cancer Center about the design, execution and implementation of clinical trials for Seminars in Radiation Oncology.
Dr Akila Viswanathan talks with Dr Daniel Low, Vice Chair of Medical Physics Research and Innovation at UCLA Health, about MR Guided Radiation Therapy for Seminars in Radiation Oncology.
Dr Akila Viswanathan talks to Dr David Kirsch from the Princess Margaret Cancer Centre/University Health Network about treating soft tissue sarcomas for Seminars in Radiation Oncology.
Dr Bill Nelson talks to Dr Ken Kinzler, cancer researcher and Co-Director of Ludwig Cancer Research at Johns Hopkins, about his work in cancer genetics, the creation of screening tests for early detection and the future of personalized medicine.
Dr Bill Nelson talks to Terri Conneran, the founder of KRAS Kickers, about the discovery of biomarkers, targeted treatments and her advocacy for patients across all cancer types.
Dr Bill Nelson talks with Dr Clayton Yates about the evolution of his research into the genetics of ancestry.
Dr Bill Nelson talks to Dr Rick Jones and Michael McCormick about their new book Rogue Cells: A Conversation on the Myths and Mysteries of Cancer. The book offers a blend of science and humor to help make the complexities of a cancer diagnosis more accessible to patients and their care partners. Learn more about the book here.
Dr Bill Nelson speaks with Christy Wyskiel, the Executive Director of Johns Hopkins Technology Ventures, about the journey scientific discoveries take on their way to becoming life-saving treatments and the role JHTV plays in commercializing medical innovations.
Dr Ashwani Rajput speaks with Dr Gordon Gao from the Johns Hopkins Carey School of Business about Digital Health, Artificial Intelligence and using technology to improve outcomes for patients.
Dr Ashwani Rajput speaks with Laurie Singer, a member of the Kimmel Cancer Center's Advisory Board and advocate for patients and their caregivers, about the role of caregiving and the necessities they provide throughout the cancer journey.
Dr Akila Viswanathan speaks with Dr Carmen Kut about the expanded neuro-oncology and central nervous system cancer treatment options available to patients from Johns Hopkins in the Greater Washington DC Area.
Dr Akila Viswanathan speaks with Dr Jesse Aronowitz, Emeritus Historian of the American Brachytherapy Society, about the history of the use of brachytherapy to treat cancer and the contributions of two early pioneers in the field from Johns Hopkins, Howard Kelly and Hugh Hampton Young.
In this podcast looking back at the last 50 years of the Cancer Center at Johns Hopkins, Dr Bill Nelson and Dr Julie Brahmer examine the breakthroughs made by some of our leaders in lung cancer care and research and review the evolution of treatment over decades that is leading to longer and more durable survival in patients.
Dr Bill Nelson and Dr Alison Klein discuss her work investigating the gene mutations that create a family history of pancreatic cancer.
Dr Bill Nelson speaks with Eben Block, a colorectal cancer survivor and co-organizer of Cycling to End Cancer, a fundraiser to benefit the Colorectal Cancer Center of Excellence at Johns Hopkins. To learn more, donate or start riding, click here.
Dr Bill Nelson speaks with Dr David Sidransky about his contribution to launching the field of DNA detection research.
Dr Bill Nelson talks to Dr Ken Pienta about his efforts to define cancer. Read the article Dr Pienta co-authored here.
Dr Ashwani Rajput talks with Dr Solmaz Sahebjam about the treatment of tumors in the brain and along the spine.
Dr Bill Nelson and Dr Ashi Weeraratna look back at her experiences as a cancer researcher and forward to where research at Johns Hopkins is heading.
Dr Ashwani Rajput speaks with radiologist Dr Pouneh Razavi about the importance of mammography in the early detection of breast cancer, the process of breast imaging, and the multidisciplinary approach to a breast cancer diagnosis at Johns Hopkins in the Greater Washington DC Area.
Dr Bill Nelson talks with Dr Chi Dang about his research into oncogenes and they reflect on the spirit of discovery through research that has been fostered at Johns Hopkins.
Dr Ashwani Rajput speaks with Maureen Umeh, a reporter and anchor for FOX 5 in Washington DC, about her career in news, serving as a voice for immigrant communities, and tackling health disparities in the nation's capital.
Dr Bill Nelson and Dr Cole Sterling discuss the latest treatment options available for patients with lymphoma.
Dr Akila Viswanathan talks with Dr Robert Ivkov about his research using nanoparticles to target tumors and boost immune response.
Dr Akila Viswanathan and Dr Tracy Balboni from Harvard Medical School and Dana-Farber/Brigham and Women's Cancer Center discuss the latest developments in palliative care for Seminars in Radiation Oncology.
Dr Bill Nelson talks with Dr Stephen Baylin about his work in cancer epigenetics and his long tenure spanning the history of our Cancer Center.
Dr Akila Viswanathan speaks with Dr Fred Bunz about his work creating viruses that can be used to boost the immune response to cancer.
Dr Akila Viswanathan and Medical Physicist Dr Weihua Mao discuss how physicists assist radiation oncologists in designing treatment plans for patients.
Dr Akila Viswanathan speaks with Dr Timur Mitin from Oregon Health and Science University about bladder cancer for Seminars in Radiation Oncology.
Dr Ashwani Rajput and Dr Mark Markowski, the Director of Genitourinary Oncology in the Washington DC Region, discuss the multidisciplinary approach to bladder cancer and the treatment of genitourinary cancers in men.
Dr Akila Viswanathan speaks with Dr Noam VanderWalde from the West Cancer Center and Research Institute and Dr Ben Movsas from the Henry Ford Cancer Institute about the personalization of cancer care for older adults for Seminars in Radiation Oncology.
Dr Akila Viswanathan speaks with Dr Ke Sheng from the University of California San Francisco and Dr CL Brouwer from the University of Groningen about the emergence of artificial intelligence for Seminars in Radiation Oncology.
Dr Bill Nelson and Dr John Groopman review some of the first leaders who played a key role in the emergence of public health and cancer prevention.
Five-time Paralympian and 29-time medalist, Jessica Long joins Dr Bill Nelson to discuss her long career as a swimmer and Swim Across America Baltimore's upcoming Open Water Swim and Pool Swim later this summer that raise money for cancer research at the Johns Hopkins Kimmel Cancer Center. To sign up, volunteer or donate, visit swimacrossamerica.org.
Dr Bill Nelson and Dr Otis Brawley analyze the successes that have been made in reducing cancer mortality as well as the necessary next steps in prevention and screening.
Dr Akila Viswanathan speaks with Dr William Li, physician, scientist and best-selling author of "Eat To Beat Your Diet: Burn Fat, Heal Your Metabolism and Live Longer" about using the food we eat to prevent diseases like cancer. To learn more about Dr Li's work and his book, visit drwilliamli.com.
In this podcast celebrating the 50th Anniversary of the Johns Hopkins Kimmel Cancer Center, Dr Akila Viswanathan speaks to Dr John Wong, Professor Emeritus and former Director of Medical Physics, about the 20th Anniversary of the Department of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins and the significant scientific achievements he has overseen throughout his tenure.
Dr Bill Nelson speaks with Donna Berizzi, the Senior Director of Oncology Nursing at Johns Hopkins, about the past, present and future of oncology nursing.
Dr Bill Nelson and Dr Elizabeth Jaffee highlight some of the first women to make significant contributions in our Cancer Center, including Dr Judy Karp and Dr Paula Pitha-Rowe, as well as pointing out the obstacles they were forced to overcome.
Dr Bill Nelson talks with Dr Rick Jones about the genesis of the bone marrow transplant program at Johns Hopkins, the breakthroughs over the last five decades that have led to increasingly better outcomes for patients, and the founder of the BMT Program, Dr George Santos.
Dr Bill Nelson and Dr Ross Donehower discuss the origins of the drug development program at our cancer center and the first director, Dr O. Michael Colvin.
In the next podcast looking back at the first 50 years of the cancer center at Johns Hopkins, Dr Bill Nelson speaks with Dr Steven Piantadosi about the origin of quantitative sciences in cancer research.
Dr Bill Nelson speaks with Dr Srinivasan Yegnasubramanian and Dr Sean Taverna about their research into cell function and how that knowledge can be used to detect and prevent disease.
Dr Bill Nelson and Dr Ted DeWeese, the interim Dean of Faculty and CEO of Johns Hopkins Medicine, review the history of radiation oncology at Johns Hopkins.
In this edition of our podcast series on the history of our cancer center, Dr Bill Nelson speaks to Ed Miller, the former Dean of the Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine, about the second Director of the Johns Hopkins Kimmel Cancer Center, Dr Martin Abeloff.
Dr Bill Nelson speaks with Dr John Groopman from the Johns Hopkins Bloomberg School of Public Health about identifying the causes of cancer and developing strategies to prevent exposure and advance treatment methods.
Dr Ashwani Rajput talks with Dr Khaled El-Shami about the diagnosis, treatment, and care for patients with leukemias, lymphomas, and myelomas.
In the second edition of our podcast series looking back on the history of the Johns Hopkins Kimmel Cancer Center, Dr Bill Nelson speaks with Dr Donald Small, the Director of Pediatric Oncology, about the role Johns Hopkins played in the creation of the discipline of pediatric oncology.
Dr Akila Viswanathan and Dr Jean Wright discuss the most recent recommendations for treating breast cancer with radiation as part of our series for Seminars in Radiation Oncology.
2023 marks the 50th anniversary of the founding of the cancer center at Johns Hopkins. In recognition, this year will feature a series of podcasts looking back at the individuals that made our institution what it is today. We begin with Dr Bill Nelson speaking to Dr Jonathan Simons about the first leaders of the cancer center, Dr Albert Owens and Dr Donald Coffey.
Dr Bill Nelson speaks with Lindsey Ledwin, a patient diagnosed with Chronic Myeloid Leukemia in 2018, and Dr Tania Jain one of her oncologists, about her cancer journey and advocacy for other patients being treated at the Johns Hopkins Kimmel Cancer Center.
Dr Bill Nelson speaks with Dr Valsamo Anagnostou, the Co-Director of the Johns Hopkins Kimmel Cancer Center's molecular tumor board, to explain what they do and how their work contributes to the treatment and care of patients with cancer.
Dr Bill Nelson speaks with Dr Ralph Hruban, co-author of the new book, A Scientific Revolution: Ten Men and Women Who Reinvented American Medicine, about the founders of the Johns Hopkins University School of Medicine and the generations of leaders in research and patient care that they would inspire.
Click here for more information or to purchase the book.
Dr Bill Nelson speaks with Dr Ralph Hruban, co-author of the new book, A Scientific Revolution: Ten Men and Women Who Reinvented American Medicine, about the founders of the Johns Hopkins University School of Medicine and the generations of leaders in research and patient care that they would inspire.
Click here for more information or to purchase the book.
Dr Otis Brawley speaks with Dr Qasim Hussaini, a Fellow in the Hematology and Medical Oncology Fellowship Program, about a study he recently presented on the impact of historical housing discrimination on present-day colon cancer outcomes.
Dr Otis Brawley speaks with Dr Qasim Hussaini, a Fellow in the Hematology and Medical Oncology Fellowship Program, about a study he recently presented on the impact of historical housing discrimination on present-day colon cancer outcomes.
Dr Akila Viswanathan speaks with Dr Xun Jia, Director of the Medical Physics Division at Johns Hopkins, on how physicists help create and execute radiation treatments for patients with cancer.
Dr Akila Viswanathan talks with Dr Michael Goldstein about his research into DNA Damage Response and how the damage to the DNA of cancer cells can be exploited to better treat patients.
Dr Ashwani Rajput speaks with Dr Karim Boudadi about treating head and neck cancers, including HPV-related cancers.
Dr Ashwani Rajput speaks with the Very Reverend Randy Hollerith, Dean of the Washington National Cathedral, about racial reconciliation, disparities in health care, and finding hope in discovery.
Learn more about the Cathedral at cathedral.org.
Dr Bill Nelson speaks with Dr Ambereen Mehta and Dr Nathan Gray from the Palliative Care Program at Johns Hopkins Bayview Medical Center about the many ways patients can benefit from palliative care.
Dr Ashwani Rajput speaks with Claire Oppert, a musician, teacher and therapist, about her work playing the cello for patients and her research into the healing power of music.
Dr Ashwani Rajput speaks with Dr Gerald Andriole, Director of the Johns Hopkins Brady Urological Institute in the National Capital Region, about the treatment of prostate cancer and The Brady's commitment to excellent patient care, breakthrough research, and training of the next generation of physicians.
Dr Ashwani Rajput talks with Dina Lansey, Associate Deputy Director of Community Outreach and Engagement, about the Kimmel Cancer Center's efforts to partner with our communities to address cancer disparities and improve healthcare outcomes.
Dr Bill Nelson speaks with Dr Rebecca Stone about a new approach to reducing the risk of ovarian cancer.
Dr Bill Nelson talks with Dr Anne Marie Lennon from the Johns Hopkins Kimmel Cancer Center and Dr Jonathan Simons from the Marcus Foundation about a significant study that shows the majority of patients with stage II colon cancer no longer need chemotherapy following surgery.
Dr Ashwani Rajput talks with Dr Ben Levy from Sibley Memorial Hospital about the results of the Checkmate-816 clinical trial, which is leading to major changes in the way patients with non-small cell lung cancer are being treated. Click here to learn more about the Checkmate-816 trial.
Dr Bill Nelson speaks with Dr Patrick Forde about the results of a clinical trial that show pairing immunotherapy treatments with chemotherapy greatly increases survival in patients with lung cancer.
Read more about the Checkmate-816 Trial here.
Dr Bill Nelson speaks with Dr Channing Paller from the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington DC and Dr Heather Cheng from the Fred Hutchinson Cancer Research Center about the PROMISE prostate cancer registry. The PROMISE registry is studying the role of genetics in determining health outcomes for patients with prostate cancer. Learn more about PROMISE at prostatecancerpromise.org/
Johns Hopkins Kimmel Cancer Center Director, Dr Bill Nelson, talks with singer and songwriter Martha Wainwright about her career, her mother's battle with sarcoma and Stand Up To Cancer's Kate McGarrigle Fund Music As Healing Program.
The grant program is an initiative Stand Up To Cancer Canada that encourages cancer patients and survivors to share their cancer journey through original music with up to 10 finalists being chosen to receive $2,500 to support the professional recording of their original song.
To learn more or to apply, visit standuptocancer.org/musicashealing
Dr Bill Nelson speaks to Dr Kathy Ruble about her work on cognitive development with survivors of pediatric cancers.
Dr Ashwani Rajput speaks with survivor, mentor, patient advocate, podcast host, and champion for female researchers in oncology, Brenda Brody, about her breast cancer journey and how she is using what she learned along the way to help others.
Listen to Brenda's own podcast series, in partnership with the ASCO Foundation and the Conquer Cancer Foundation, here.
Read more about her work with Hope Connections here.
Dr Akila Viswanathan talks with Dr Robert Timmerman from UT Southwestern about radiation therapy for oligometastatic disease as part of our series for Seminars in Radiation Oncology.
Dr Ashwani Rajput talks with Dr Stephen Broderick and Dr Andrew Lerner about the multidisciplinary approach to lung cancer care at Johns Hopkins in the greater Washington DC area.
Dr Akila Viswanathan speaks with Dr Sahaja Acharya, Director of Pediatric Radiation Oncology, about treating children with brain tumors.
Dr Akila Viswanathan and Dr Aditya Halthore discuss the treatment of patients with lung and genitourinary cancers at the Johns Hopkins Proton Therapy Center located at Sibley Memorial Hospital in Washington DC.
Dr Akila Viswanathan speaks with Dr Philipp Oberdoerffer about his research on how cells function or stop functioning, and how that can result in diseases like cancer.
Dr Akila Viswanathan talks with Dr Wilfred Ngwa about both his work as the Director of the Global Health Catalyst, which aims to reduce cancer health disparities around the world, and his research pairing medical physics with immunotherapy.
Learn more at globalhealthcatalystsummit.org
Dr Bill Nelson speaks with Dr Donald L Trump and Eric Rosenthal about their new book, Centers of the Cancer Universe: A Half-Century of Progress Against Cancer.
For more information or to purchase the book, visit: https://rowman.com/ISBN/9781538144893/Centers-of-the-Cancer-Universe-A-Half-Century-of-Progress-Against-Cancer
Dr Bill Nelson speaks with Dr Vered Stearns, Dr Wen Shen and patient advocate Kate Pisano about the Johns Hopkins Women's Wellness Program that helps guide women through their cancer treatment, recovery, and care continuum. For more information about the program, email womenswellness@jhmi.edu.
Dr Bill Nelson talks with Dr Janis Taube and Dr Alex Szalay about AstroPath, a new platform that combines astronomy with pathology to identify predictive biomarkers for cancer immunotherapy.
Dr Ashwani Rajput talks with Dr Gabriel Ivey about his experience in the Johns Hopkins Surgical Oncology Fellowship Program.
Dr Akila Viswanathan and Dr Matthew Ladra discuss the use of proton therapy with pediatric patients.
Dr Akila Viswanathan talks with Dr Curtiland Deville, the Medical Director of the Johns Hopkins Proton Therapy Center, and Dr Heng Li, the Chief Proton Physicist of the Johns Hopkins Proton Therapy Center, about the treatment options and research potential for proton therapy.
Learn more at hopkinsproton.org.
Dr Akila Viswanathan speaks with Dr Ramesh Rengan and Dr Jing Zeng, both from the Department of Radiation Oncology at the University of Washington Medicine, about treatment advances in non small-cell lung cancer for Seminars Radiation Oncology.
Dr Bill Nelson talks with Author Sam Apple about his new book, Ravenous: Otto Warburg, The Nazis, And The Search For The Cancer-Diet Connection.
For more information about Sam's book, visit: https://www.amazon.com/Ravenous-Warburg-Search-Cancer-Diet-Connection/dp/1631493159
Dr Ashwani Rajput speaks with Carolyn Carpenter, the President of the Johns Hopkins Health System in the National Capital Region, about her career path in healthcare administration and her vision for Johns Hopkins and the Kimmel Cancer Center in the greater Washington DC area.
Dr Akila Viswanathan talks with Dr Ana Kiess from Johns Hopkins and Dr John Buatti from the University of Iowa to review the latest edition of Seminars in Radiation Oncology focusing on ‘Theranostics,’ the combining of therapeutic and diagnostic radiopharmaceuticals.
Dr Bill Nelson talks with Mike Armstrong, Dr Julie Brahmer, and breast cancer survivor and advocate Christine Hodgdon to discuss Mike's book, Cancer with Hope, and about the promise of future treatments provided through clinical trials.
Dr Ashwani Rajput talks with medical student George Zhang about his educational path to becoming a doctor, pursuing a master's degree at the Johns Hopkins Bloomberg School of Public Health, and his upcoming residency at Brigham and Women's Hospital.
Dr Bill Nelson speaks with Tyler Jacks, the President of Break Through Cancer, a collaborative partnership between The Johns Hopkins Kimmel Cancer Center, The Dana Farber Cancer Institute, The Koch Institute for Integrative Cancer Research at MIT, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center designed with the goal of curing the most lethal cancers.
Dr Bill Nelson talks with Mike Armstrong, Dr Vered Stearns, patient navigator and community outreach advisor Jill Mull, and attorney Leslie Riesabout Mike's book, Cancer with Hope, and how focusing on purpose can give patients a sense of direction following a cancer diagnosis.
Dr Ashwani Rajput and Dr Haniee Chung discuss the screening and surgical options for colorectal cancer. March is colorectal cancer awareness month, so remember to speak with your doctor about the right time to begin screening.
Johns Hopkins Kimmel Cancer Center Director Dr Bill Nelson speaks with Trey Mancini of the Baltimore Orioles and Dr Nilofer Azad about Trey's treatment, and return to baseball, following a diagnosis of colon cancer.
Dr Bill Nelson speaks with Mike Armstrong and Eric Vohr, co-authors of the new book, Cancer with Hope, along with oncology research nurse Anna Ferguson about the role hope plays in each individual cancer diagnosis.
Learn more about the book here: jhupbooks.press.jhu.edu/title/cancer-hope
Dr Bill Nelson and Dr Elizabeth Jaffee discuss the creation of Break Through Cancer, a new collaborative partnership between The Johns Hopkins Kimmel Cancer Center, The Dana Farber Cancer Institute, The Koch Institute for Integrative Cancer Research at MIT, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center that will help accelerate research, clinical trials, and new treatments for the most lethal cancers.
To learn more about Break Through Cancer, visit breakthroughcancer.org.
March is Colorectal Cancer Awareness Month and in this Kimmel in DC podcast, Dr Ashwani Rajput speaks with Dr Valerie Lee about the importance of screening as well as the diagnosis and treatment for patients who develop the disease.
Dr Bill Nelson speaks with Mike Armstrong and Eric Vohr about their new book, Cancer with Hope, which chronicles how hope and purpose helped Mike and other cancer patients manage the many challenges associated with this devastating disease.
Learn more about the book here: jhupbooks.press.jhu.edu/title/cancer-hope
Dr Bill Nelson speaks with Dr Lauren Berninger, Dr Pat Carroll and Pharmacist Julie Waldfogel about pain management for patients with cancer at risk for substance abuse.
Dr Bill Nelson speaks with Paul Goldberg, Editor of the Cancer Letter, and Dr Otis Brawley about the Cancer History Project.
Visit the Cancer History Project website at cancerhistoryproject.com
Dr Ashwani Rajput and Dr Maureen O'Donnell discuss the surgery options for patients diagnosed with breast cancer.
Dr Ashwani Rajput talks with Dr Michael Pishvaian about treating patients with gastrointestinal cancers, specifically colorectal cancer and pancreatic cancer, as well as the importance of clinical trials in developing improved standard practices of care.
Dr Bill Nelson speaks with Dr J James Frost about his recent paper, 'Cancer's Intelligence,' on how the disease plots its growth in the body to overcome our efforts to stop it.
To read more on Dr Frost's work, click here: eurekalert.org/pub_releases/2020-12/swbc-ci122220.php
Dr Bill Nelson talks to Dina Lansey and Dr Otis Brawley about their work using resources from the state of Maryland's Cigarette Restitution Fund to educate patient populations on the benefits of clinical trials and overcome barriers to participation.
Dr Akila Viswanathan and the COVID-19 response team from the Department of Radiation Oncology and Molecular Radiations Sciences provide an update on our response to the COVID-19 pandemic.
Dr Bill Nelson and Dr Alex Baras explain how doctors and scientists are examining large data sets to improve and refine cancer care.
Dr Akila Viswanathan talks with Dr Fred Bunz about cancer genetics and the cell mutations that lead to the growth and spread of cancer.
Dr Akila Viswanathan speaks with Dr Junghoon Lee about the role of imaging in cancer treatment and how artificial intelligence continues to improve patient care.
Dr Ashwani Rajput, the Director of the Johns Hopkins Kimmel Cancer Center in the National Capital Region, begins his podcast series speaking with Dr Ben Levy from Sibley Memorial Hospital about the treatment of lung cancer and the cancer services available through the Kimmel Cancer Center in the Greater Washington DC Area.
Dr Bill Nelson and Dr Tatiana Prowell discuss the approval and regulation of cancer drugs by the Food and Drug Administration.
Dr Bill Nelson and Dr Pat Brown discuss the treatment methods for patients diagnosed with Acute Lymphoblastic Leukemia (ALL), including CAR-T cell therapy.
In a broad discussion, Dr Otis Brawley and Dr Curtiland Deville from Sibley Memorial Hospital discuss the range of available treatments for prostate cancer, reducing cancer disparities, and increasing minority representation in radiation oncology.
Dr Otis Brawley speaks with Dr John Kiess of Loyola University about reconciliation, peacebuilding and how social change can improve healthcare disparities.
Dr Kiess's book is entitled Hannah Arendt and Theology.
Dr Otis Brawley and Dr David Terry, from Morgan State University, discuss the long history and relationship between Johns Hopkins University and Hospital with the African American community of Baltimore.
Dr Terry's book is entitled, The Struggle and the Urban South: Confronting Jim Crow in Baltimore Before the Movement.
Dr Bill Nelson and Dr Emmanuel Antonarakis explain how PARP Inhibitors work and their use in treating some types of prostate cancer.
Dr Akila Viswanathan and Dr Junzo Chino from the Duke Cancer Institute examine the American Society for Radiation Oncology Clinical Guidelines on Radiation Therapy for Cervical Cancer.
To read the full guidelines, click here: https://www.astro.org/Patient-Care-and-Research/Clinical-Practice-Statements/Cervical-Cancer-Guideline
Dr Bill Nelson speaks with Dr Mark Yarchoan about the diagnosis and treatment of liver cancer.
Dr Bill Nelson speaks with Dr Mario Eisenberger about treating advanced-stage prostate cancer.
Dr Bill Nelson talks with Dr Ken Cooke about the success of pediatric bone marrow transplants.
Dr Akila Viswanathan speaks Dr Harry Quon, the Co-Director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic.
Dr Bill Nelson speaks with Dr Bert Vogelstein about shifting his work as a cancer researcher to detecting and preventing the spread of COVID-19.
Dr Bill Nelson and Dr Otis Brawley discuss why the poor and disadvantaged that are already struggling with a cancer diagnosis are also more susceptible to COVID-19.
Dr Bill Nelson and Dr Ashwani Rajput, the Director of the Johns Hopkins Kimmel Cancer Center in the National Capital Region, discuss how the Johns Hopkins Health System will deal with a backlog of cancer surgeries that were delayed by COVID-19.
Dr Akila Viswanathan and Dr Ana Kiess discuss the treatment of HPV-related head and neck cancers and the future of radiopharmaceuticals.
Dr Akila Viswanathan talks with Dr Todd McNutt about his research into medical physics and clinical informatics and how data collection can improve patient care.
Dr Bill Nelson and Dr Carol Ann Huff explain how the Johns Hopkins Kimmel Cancer Center is handling the COVID-19 pandemic and adjusting to treat patients who contract the virus.
Dr Akila Viswanathan speaks to Dr Robert Hobbs about his research into radiopharmaceuticals, alpha particle therapy and dosimetry based treatment.
Dr Akila Viswanathan speaks with Dr Phuoc Tran about his research into the spread of prostate cancer and a clinical trial that may show a response from the immune system for patients undergoing SBRT treatment.
In this special edition of the On Target podcast, Dr Akila Viswanathan speaks with members of the Johns Hopkins Radiation Oncology COVID-19 response team about the protocols and patient procedures implemented throughout Johns Hopkins Medicine to ensure cancer patients continue to receive their care and remain safe from the Coronavirus.
Dr Rosanne Sheinberg and Harpreet Gujral explain the cancer-related risks associated with obesity and how the concept of NEAT (Non-exercise Activity Thermogenesis) plays a crucial role in maintaining a healthy weight.
Dr Bill Nelson talks with Dr Panagis Galiatsatos about the dangers of smoking or vaping and the science behind nicotine addiction.
Dr Rosanne Sheinberg and Harpreet Gujral discuss the importance of a healing environment as well as some recent additions to Sibley Memorial Hospital that aid patients in their recovery process.
Dr Bill Nelson talks to Jeanine Pennington, Portfolio Director for Johns Hopkins Technology Ventures, about the assistance they provide to researchers in finding partnerships, managing the legal and regulatory process and, in some cases, helping to start companies to bring the discoveries and innovations found in the lab to patients diagnosed with cancer.
Dr Bill Nelson and Dr Jonathan Powell discuss how T cells activated from the immune system are being used to fight cancer.
Dr Rosanne Sheinberg and Harpreet Gujral explain the benefits of exercise for patients with cancer.
Dr Bill Nelson and Dr Cynthia Zahnow discuss how her experience as a breast cancer survivor informs her research into examining a potential link between alcohol consumption and breast cancer.
Dr Akila Viswanathan is joined by Dr Sara Alcorn to discuss the treatment of sarcoma and explain the use of radiation in palliative care.
Dr Bill Nelson speaks with thoracic surgeon Dr Stephen Broderick about the latest developments in lung cancer care that have made lung surgery less debilitating and improved patient outcomes.
Dr Rosanne Sheinberg and Harpreet Gujral discuss how isolation and loneliness can negatively impact people undergoing cancer treatment.
Dr Bill Nelson speaks with Dr Valerie Lee about the treatment of anal and rectal cancers.
Dr Akila Viswanathan talks with Dr Andrew Ewald about the Johns Hopkins Cancer Invasion and Metastasis Program and the importance of providing more research to the spread of cancer.
Dr Bill Nelson speaks with Dr Venu Raman about his work to develop a cancer drug targeting a gene that stabilizes tumors.
Dr Rosanne Sheinberg and Harpreet Gujral from Sibley Integrative Medicine talk with cancer survivor Martha Brettschneider, whose diagnosis opened a door to mindfulness and set her life on a new path.
Dr Akila Viswanathan and Dr Amol Narang discuss how radiation oncologists at Johns Hopkins are addressing the challenges of treating pancreatic cancer.
Dr Bill Nelson speaks with Elizabeth Platz, from the Bloomberg School of Public Health, about how epidemiologists and population scientists determine the causes of cancer as well as the importance of diet and exercise in preventing cancer.
Dr Otis Brawley speaks with Dr Michael Carducci about the benefit of clinical trials and his work treating patients with prostate cancer.
Dr Rosanne Sheinberg and Harpreet Gujral from Sibley Integrative Medicine talk to Margaret Cohen and Kristen Pruski from the Sibley Memorial Hospital Foundation about the benefits of charitable giving and the differences that donations can make in the health outcomes of others.
Dr Bill Nelson talks with three-time cancer survivor Kristina Baum about the challenges of confronting her disease and successfully running the New York Marathon in November.
Dr Bill Nelson talks with Dr Julie Brahmer about the advances made in treating patients with lung cancer, smoking cessation and lung cancer screening.
Dr Rosanne Sheinberg and Harpreet Gujral from Sibley Integrative Medicine explore the phenomenon of 'Blue Zones,' certain places around the world where people live happier, healthier and longer.
Dr Bill Nelson speaks with Dr Christina Tsien, Medical Director of the new Johns Hopkins Proton Therapy Center at Sibley Memorial Hospital, about the science behind proton therapy.
Dr Otis Brawley speaks with Rebka Atnafou from the Johns Hopkins Urban Health Institute and Bloomberg School of Public Health about her work to improve community engagement in Baltimore.
Dr Akila Viswanathan speaks with Dr Daniel Song about the Multidisciplinary Prostate Cancer Clinic at the Johns Hopkins Kimmel Cancer Center and the treatment of genitourinary cancers.
Dr Rosanne Sheinberg and Harpreet Gujral offer up some tips for getting through the stresses of the holiday season.
Dr Bill Nelson speaks with Dr Victor Velculescu about a test that can detect cancer DNA in the bloodstream.
Dr Akila Viswanathan talks to Dr Robert Ivkov about his research into nanoparticles and thermal cancer treatment.
Dr Bill Nelson speaks with Dr B Douglas Smith about treating leukemia patients with targeted therapies that reduce toxicities while also improving outcomes.
Harpreet Gujral talks with Dr Neal Barnard, President of the Physicians Committee for Responsible Medicine, about the positive impact a healthy diet and exercise can have on brain health.
Dr Bill Nelson speaks with Dr Gregg Semenza about his research into how cells adapt to the amount of oxygen in their environment that won him the 2019 Nobel Prize in physiology or medicine.
Dr Akila Viswanathan talks with Dr Sara Alcorn about the multidisciplinary approach to treating breast cancer and how the use of radiation is becoming more personalized to each patient.
Dr Bill Nelson and Dr Ashani Weeraratna discuss how melanoma can arise through changes in our skin as we age.
Dr Rosanne Sheinberg and Clinical Dietary Specialist Renee Cha provide some options for making healthier choices at lunch.
Dr Bill Nelson talks with Dr Cynthia Sears about her research into the importance of the microbiome on our overall health.
Dr Akila Viswanathan talks with Dr Russell Hales about the thoracic oncology multidisciplinary program available at the Johns Hopkins Kimmel Cancer Center.
Dr Rosanne Sheinberg and Harpreet Gujral speak to Dr Bahareh Amidi about the power of poetry therapy. For more information on Dr Amidi, visit her website at bahareh.com.
Dr Akila Viswanathan speaks with Dr Lawrence Kleinberg about the treatment of brain cancer and engaging the immune system to combat tumors.
Dr Bill Nelson discusses the multidisciplinary approach to treating brain tumors with Dr Matthias Holdhoff.
Dr Otis Brawley talks to Dr Avonne Connor from the Bloomberg School of Public Health about her research into co-morbid conditions and breast cancer disparities.
Dr Rosanne Sheinberg and Harpreet Gujral from Sibley Integrative Medicine discuss the importance of the microbiome to our overall health.
Dr Bill Nelson talks with Dr Lei Zheng from the Bloomberg~Kimmel Institute for Cancer Immunotherapy about his research into how the immune system can be used to respond to pancreatic cancer.